Medical Device Investing Medtronic to announce financial results for its first quarter of fiscal year 2026
Medical Device Investing Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
Medical Device Investing Medtronic secures CE Mark for MiniMed 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes
Medical Device Investing Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company
Medical Device Investing Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
medical device investing Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference
medical device investing Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase
medical device investing Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones
medical device investing Medtronic to announce financial results for its fourth quarter and full fiscal year 2025
medical device investing New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women
medical device investing Medtronic Affera pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients
medical device investing Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo robotic-assisted surgery system
medical device investing Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure lead and announces investigational clinical study results
Quimbaya Gold Starts Drilling at Tahami South, Testing Undrilled Gold System Beside Aris' Segovia Mine
